powered by
▸
healthparse
Search
Cohort Builder
Tools
▾
KOL Finder
Territories
Drug Compare
AI Query
Research
Browse
▾
By state
By specialty
Pricing
Search
Cohort Builder
Tools
KOL Finder
Territories
Drug Compare
AI Query
Research
Browse
By state
By specialty
Pricing
PROVIDER PROFILE · NPI 1497982649
Melissa Burgess
M.D.
Hematology-Oncology
Pittsburgh,
PA
I
CROSS-REFERENCE
Related data on other Healthparse brands
ProviderScore
OIG/SAM exclusion screening, sanctions history
Healthparse Signals
Monitor this provider for changes — dated NPI change events
QUALITY · MIPS · 2024
Final MIPS score
80.9
Quality
61.9
Cost
74.6
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
0.25%
Group
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$211
Payment records
2
By payment type
Food and Beverage
$211
Top paying entities
Food and Beverage
$211
PRESCRIBING · PART D · 2024
Total Rx claims
388
Beneficiaries
—
Total drug cost
$1.4M
Distinct drugs
17
Brand share
25.5%
Top prescribed drugs
Pazopanib Hcl
52 claims
Ondansetron Hcl
43 claims
Imatinib Mesylate
42 claims
Sorafenib Tosylate
31 claims
Gabapentin
25 claims
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
204
Unique beneficiaries
—
Total services
324
Distinct HCPCS
8
Medicare payment
$26K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 417 Hematology-Oncology providers in PA — bottom quintile (cohort median 753).
